The New England journal of medicine
-
The American Medical Political Action Committee (AMPAC), the political arm of the American Medical Association (AMA), contributed $2.4 million to candidates for Congress during the 1989-1990 campaign and $2.9 million during the 1991-1992 campaign. It is not known whether these funds preferentially benefited representatives who supported the AMA's positions on public health issues. ⋯ AMPAC's contributions to members of the House of Representatives belie the AMA positions on some important public health issues.
-
Randomized Controlled Trial Clinical Trial
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
Dermatomyositis is a clinically distinct myopathy characterized by rash and a complement-mediated microangiopathy that results in the destruction of muscle fibers. In some patients the condition becomes resistant to therapy and causes severe physical disabilities. ⋯ High-dose intravenous immune globulin is a safe and effective treatment for refractory dermatomyositis.